These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34127256)

  • 1. Reactivation of Strongyloides stercoralis in patients with SARS-CoV-2 pneumonia receiving dexamethasone.
    Feria L; Torrado M; Anton-Vazquez V
    Med Clin (Barc); 2022 Mar; 158(5):242-243. PubMed ID: 34127256
    [No Abstract]   [Full Text] [Related]  

  • 2. Strongyloides infection manifested during immunosuppressive therapy for SARS-CoV-2 pneumonia.
    Marchese V; Crosato V; Gulletta M; Castelnuovo F; Cristini G; Matteelli A; Castelli F
    Infection; 2021 Jun; 49(3):539-542. PubMed ID: 32910321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of Strongyloides Hyperinfection Syndrome when prescribing dexamethasone in severe COVID-19.
    De Wilton A; Nabarro LE; Godbole GS; Chiodini PL; Boyd A; Woods K
    Travel Med Infect Dis; 2021; 40():101981. PubMed ID: 33535106
    [No Abstract]   [Full Text] [Related]  

  • 4. Dexamethasone and COVID-19: Strategies in Low- and Middle-Income Countries to Tackle Steroid-Related Strongyloides Hyperinfection.
    Olivera MJ
    Am J Trop Med Hyg; 2021 Mar; 104(5):1611-1612. PubMed ID: 33720844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strongyloides Hyperinfection Syndrome among COVID-19 Patients Treated with Corticosteroids.
    Kim JM; Sivasubramanian G
    Emerg Infect Dis; 2022 Jul; 28(7):1531-1533. PubMed ID: 35731220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of the drugs used in migrant patients with severe acute respiratory syndrome coronavirus 2 and the development of symptomatic strongyloidiasis.
    Lorenzo H; Carbonell C; Vicente Santiago MB; López-Bernus A; Pendones Ulerio J; Muñoz Bellido JL; Muro A; Belhassen-García M
    Trans R Soc Trop Med Hyg; 2022 May; 116(5):440-445. PubMed ID: 34614186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for strongyloidiasis in Spain in the context of the SARS-CoV-2 pandemic: Results of a survey on diagnosis and treatment.
    Rodríguez-Guardado A; Álvarez-Martínez MJ; Flores MD; Sulleiro E; Torrús-Tendero D; Velasco M; Membrillo FJ;
    Enferm Infecc Microbiol Clin (Engl Ed); 2023; 41(6):329-334. PubMed ID: 35970704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 and Dexamethasone: A Potential Strategy to Avoid Steroid-Related Strongyloides Hyperinfection.
    Stauffer WM; Alpern JD; Walker PF
    JAMA; 2020 Aug; 324(7):623-624. PubMed ID: 32761166
    [No Abstract]   [Full Text] [Related]  

  • 9. An unusual cause of pneumonia: Strongyloides stercoralis infection.
    Lu CJ; Zhang JY; Huang WF
    Korean J Intern Med; 2023 Sep; 38(5):781-782. PubMed ID: 37334510
    [No Abstract]   [Full Text] [Related]  

  • 10. Pulmonary Infection Caused by Strongyloides stercoralis.
    Xu L; He Q; Chen L; Lv J; Tang Y; Li Y; Zhang Z; Wen W; Zhong G; Liu H; Fu B
    Acta Parasitol; 2022 Jun; 67(2):1044-1048. PubMed ID: 35175460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strongyloides pneumonia.
    Cataño JC; Pinzón MA
    Am J Trop Med Hyg; 2012 Aug; 87(2):195. PubMed ID: 22855744
    [No Abstract]   [Full Text] [Related]  

  • 12. High prevalence of anti-Strongyloides antibody in SARS-CoV-2-infected human sera in a Thai hospital: Rapid serological screening.
    Sadaow L; Boonroumkaew P; Rodpai R; Sanpool O; Prasongdee P; Intapan PM; Maleewong W
    J Infect Public Health; 2024 Aug; 17(8):102466. PubMed ID: 38879920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eosinophilic appendicitis due to
    Páramo-Zunzunegui J; Rubio-López L; Benito-Barbero S; Muñoz-Fernández Á
    BMJ Case Rep; 2021 Jun; 14(6):. PubMed ID: 34078621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strongyloides in bronchoalveolar lavage fluid: practical implications in the COVID-19 era.
    Norman FF; Chamorro S; Braojos F; López-Miranda E; Chamorro J; González I; Martín O; Pérez-Molina JA
    J Travel Med; 2022 Jan; 29(1):. PubMed ID: 34297094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 and strongyloidiasis: what to expect from this coinfection?
    Pereira CVM; Mastandrea GRA; Medeiros ACCS; Gryschek RCB; Paula FM; Corral MA
    Clinics (Sao Paulo); 2021; 76():e3528. PubMed ID: 34817048
    [No Abstract]   [Full Text] [Related]  

  • 16. Strongyloides stercoralis hyperinfection syndrome mimicking pseudomembranous enteritis, complicated by Escherichia coli bacteremia and Pneumocystis jirovecii pneumonia in a patient after immunosuppressive therapy: a case report.
    Cai DH; Wang J; Fang XL
    BMC Infect Dis; 2022 Sep; 22(1):749. PubMed ID: 36153480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacteremia, Liver Injury, and Pneumonitis: Strongyloides Unleashed by a Supplement.
    Xiao EY; Pecha RL; Sargsyan Z
    Am J Med; 2023 Mar; 136(3):270-272. PubMed ID: 36252707
    [No Abstract]   [Full Text] [Related]  

  • 18. Strongyloides hyperinfection syndrome following resection of meningioma.
    Shelton CL; Smith T; Karabatsou K; Ajdukiewicz K
    BMJ Case Rep; 2012 Jun; 2012():. PubMed ID: 22717933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Disseminated Strongyloides stercoralis infection mimicking pneumonia].
    Yu JJ; Lu SC; Wu IH; Yu MC; Lee CN; Lin TP
    J Formos Med Assoc; 1995 Dec; 94 Suppl 2():S162-5. PubMed ID: 8672946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass Drug Administration for the Control of Strongyloides stercoralis Infection: Progress and Challenges.
    Amato VS; Tuon FF
    Clin Infect Dis; 2020 Dec; 71(12):3229-3231. PubMed ID: 32421778
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.